Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 41Sarcoma 1Classical hematology 1CNS 1

Conditions

Sarcoma 35Osteosarcoma 22Central Nervous System Neoplasms 6Breast Neoplasms 6Stomach Neoplasms 5Ovarian Neoplasms 5Head and Neck Neoplasms 5Glioblastoma 5Colorectal Neoplasms 5Colonic Neoplasms 5Pancreatic Neoplasms 4Neuroblastoma 4Gliosarcoma 4Glioma 4Carcinoma, Non-Small-Cell Lung 4Brain Neoplasms 4Astrocytoma 4Wilms Tumor 3Sarcoma, Ewing 3Rhabdomyosarcoma 3Rectal Neoplasms 3Neuroectodermal Tumors, Primitive, Peripheral 3Neoplasms 3Neoplasm Metastasis 3Melanoma 3Esophageal Neoplasms 3Ependymoma 3Desmoplastic Small Round Cell Tumor 3Choroid Plexus Neoplasms 3Carcinoma, Ovarian Epithelial 3

Interventions

tislelizumab 1spartalizumab 1sintilimab 1milademetan 1enzalutamide 1Pemetrexed 1Midazolam 1Letrozole 1Granulocyte-Macrophage Colony-Stimulating Factor 1Fulvestrant 1Cisplatin 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma of Lung × Cisplatin × Sarcoma × Clear all
NCT04861948 2022-10-04

IBI188 Combination Therapy in Solid Tumors

Innovent Biologics (Suzhou) Co. Ltd.

Phase 1 Terminated
9 enrolled
SarcomaThoracic

Adenocarcinoma of Lung, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡